Purchase Order HHSH258200900208M

Cell Sciences, Inc. was awarded a $4,681 purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development to provide unspecified products or services in Bethesda, Maryland. The firm fixed price contract runs from September 10, 2014 through November 30, 2014. No additional details were provided regarding the original solicitation or work to be performed. Cell Sciences, Inc. will serve as the prime contractor on...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $59,293.60 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies, to provide intesticult cell cultures. This contract, which has an ultimate completion date of October 8, 2025, is not set aside for small businesses. Stemcell Technologies Inc. is a key supplier of specialized biological materials, laboratory supplies, scientific equipment, and...

Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...

Revvity Signals Software, Inc. Informatics Division, a subsidiary of Revvity Inc. Medical Imaging, LLC, has been awarded a $93,652 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide a Celleca PLX Image Cytometer in support of the Stem Cell Translation Laboratory. The solicitation sought to advance stem cell technologies for clinical application, drug discovery, and regenerative medicine through the...

STEMCELL Technologies Inc., a subsidiary of the Canadian parent company STEMCELL Technologies, received a $11,943 firm fixed-price contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on June 8, 2022. This was a Blanket Purchase Agreement (BPA) call representing a repeat order for specialized cell isolation and enrichment products, specifically an EasySep Human Pan-B Cell Enrichment Kit and custom human isolation kit components featuring CD86...

The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $40,000 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for the delivery of advanced cell diagnostics under contract number 1187802. Advanced Cell Diagnostics, Inc. will perform as the prime contractor, while its parent company Bio-Techne Corporation will provide corporate support. It is understood the National Institutes of Health aims to...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,622.50 firm fixed price purchase order to Stemcell Technologies Inc. for cell culture medium under catalog number 2201103. Stemcell Technologies, whose parent company is also Stemcell Technologies, will deliver the requested products from its location in Kent, Washington by January 31, 2024 to support the NIH/NIAID's research efforts. No subcontractors or...

This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), which is part of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $34,255.58 firm fixed-price contract is for the provision of media for the growth and maintenance of human pluripotent stem cells and induced pluripotent...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $13,507.60 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for advanced cell diagnostics services. Advanced Cell Diagnostics, Inc. will perform as the prime contractor, with its parent company listed as Bio-Techne Corporation. The contract period of performance is from November 13, 2023 through January 5, 2024. It is presumed Advanced Cell Diagnostics, Inc. will provide their...

This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $7,131.73 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call for T-cell isolation products needed for research in Dr. Kemper's lab. Stemcell Technologies Inc. is a key supplier of advanced biological materials, laboratory...